TD Waterhouse Canada’s DiaMedica Therapeutics DMAC Stock Holding History

TD Waterhouse Canada’s Portfolio DMAC Stock Details DMAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$8.94K	Hold	1,070	–	–	﹤0.01%	1914
2026 Q2	$7.97K	Hold	1,070	–	–	﹤0.01%	1882
2026 Q1	$6.84K	Hold	1,070	–	–	﹤0.01%	1845
2025 Q4	$8.51K	Hold	1,070	–	–	﹤0.01%	1588
2025 Q3	$7.34K	Hold	1,070	–	–	﹤0.01%	1610
2025 Q2	$3.81K	Hold	1,070	–	–	﹤0.01%	1640
2025 Q1	$3.96K	Hold	1,070	–	–	﹤0.01%	1582
2024 Q4	$5.8K	Hold	1,070	–	–	﹤0.01%	1524
2024 Q3	$4.45K	Hold	1,070	–	–	﹤0.01%	1520
2024 Q2	$3.12K	Hold	1,070	–	–	﹤0.01%	1586
2024 Q1	$3.88K	Hold	1,070	–	–	﹤0.01%	1579
2023 Q4	$4.05K	Sell	1,070 -500	-32%	-$1.24K	﹤0.01%	1408
2023 Q3	$4.81K	Hold	1,570	–	–	﹤0.01%	1370
2023 Q2	$8.11K	Hold	1,570	–	–	﹤0.01%	1289
2023 Q1	$3.1K	Hold	1,570	–	–	﹤0.01%	1456
2022 Q4	$2.91K	Hold	1,570	–	–	﹤0.01%	1438
2022 Q3	$2.41K	Hold	1,570	–	–	﹤0.01%	1480
2022 Q2	$3.89K	Hold	1,570	–	–	﹤0.01%	1436
2022 Q1	$4.68K	Sell	1,570 -270	-15%	-$766	﹤0.01%	1460
2021 Q4	$8.33K	Buy	+1,840	New	+$7.22K	﹤0.01%	1375

Other funds holding DMAC

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Bleichroeder LP New York $1.02B AUM 33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

TD Waterhouse Canada's DMAC Position: Q3 2026 in Review

TD Waterhouse Canada held its DiaMedica Therapeutics (DMAC) position steady in Q3 2026 at 1,070 shares worth $8.94K. The position accounts for ﹤0.01% of the portfolio, ranked #1914.

TD Waterhouse Canada first reported a position in DMAC in Q4 2021 and has held it in 20 quarters since. 67 funds tracked by Wall St. Rank hold DMAC as of Q3 2026.

TD Waterhouse Canada held 1,070 shares of DiaMedica Therapeutics worth $8.94K as of Q3 2026.
TD Waterhouse Canada left its DiaMedica Therapeutics share count unchanged in Q3 2026.
DiaMedica Therapeutics made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q3 2026, its #1914 holding.
TD Waterhouse Canada first reported a position in DiaMedica Therapeutics in Q4 2021 and has held it in 20 quarters since.
67 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q3 2026.

Based on TD Waterhouse Canada's 13F filing for Q3 2026, filed 16 Oct 2026.